UPDATE: China's fake Rx drug factories exposed, imitation Viagra "would give overdose"

30 September 2007

An undercover report by the UK's Sunday Times newspaper has revealed that a Chinese factory is allegedly producing counterfeit Viagra (sildenafil citrate) tablets with three times the permitted dose. Undercover reporters posing as representatives of a UK-based prescription drug wholesale firm were even offered large quantities of cardiovascular and oncological products.

The report claims that Gabriel Zhang, a Tianjin-based businessman, offered to manufacture 200,000 packages per month of three drugs: the antiplatelet agent Plavix (clopidogrel), which is co-marketed in the UK by France's Sanofi-Aventis and the USA-based Bristol-Myers Squibb, Anglo-Swedish drug major AztraZeneca's oncology product Casodex (bacalutamide); and US firm Eli Lilly's schizophrenia drug Zyprexa (olanzapine). All three drugs were the subject of product recalls ordered by the UK's Medicines and Healthcare products Regulatory Authority (MHRA; Marketletter June 11), after fake batches were found entering the country.

"Viagra" had excess active ingredient

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight